PMC:7190488 / 3727-4115 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/7190488","sourcedb":"PMC","sourceid":"7190488","source_url":"https://www.ncbi.nlm.nih.gov/pmc/7190488","text":"Les IVT d’anti VEGF pour néovascularisation choroïdienne inflammatoire doivent être maintenues. Comme pour la myopie forte un régime PRN est à privilégier. Si impossibilité d’examiner le patient avant IVT (pour limiter le risque de contracter le SARS-CoV-2), un régime fixe mensuel court (2 à 3 mois maximum) peut être choisi si une seule IVT n’induit pas d’amélioration visuelle notable.","tracks":[{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T12","span":{"begin":0,"end":3},"obj":"Body_part"}],"attributes":[{"id":"A12","pred":"fma_id","subj":"T12","obj":"http://purl.org/sig/ont/fma/fma63048"},{"subj":"T12","pred":"source","obj":"LitCovid-PD-FMA-UBERON"}]},{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T6","span":{"begin":246,"end":254},"obj":"Disease"}],"attributes":[{"id":"A6","pred":"mondo_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"subj":"T6","pred":"source","obj":"LitCovid-PD-MONDO"}]},{"project":"LitCovid-PD-CLO","denotations":[{"id":"T30","span":{"begin":141,"end":142},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T31","span":{"begin":289,"end":292},"obj":"http://purl.obolibrary.org/obo/CLO_0001236"}],"attributes":[{"subj":"T30","pred":"source","obj":"LitCovid-PD-CLO"},{"subj":"T31","pred":"source","obj":"LitCovid-PD-CLO"}]},{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T20","span":{"begin":156,"end":158},"obj":"Chemical"}],"attributes":[{"id":"A20","pred":"chebi_id","subj":"T20","obj":"http://purl.obolibrary.org/obo/CHEBI_27573"},{"subj":"T20","pred":"source","obj":"LitCovid-PD-CHEBI"}]},{"project":"LitCovid-sentences","denotations":[{"id":"T38","span":{"begin":0,"end":95},"obj":"Sentence"},{"id":"T39","span":{"begin":96,"end":155},"obj":"Sentence"},{"id":"T40","span":{"begin":156,"end":388},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T38","pred":"source","obj":"LitCovid-sentences"},{"subj":"T39","pred":"source","obj":"LitCovid-sentences"},{"subj":"T40","pred":"source","obj":"LitCovid-sentences"}]},{"project":"LitCovid-PubTator","denotations":[{"id":"62","span":{"begin":15,"end":19},"obj":"Gene"},{"id":"63","span":{"begin":0,"end":3},"obj":"Gene"},{"id":"64","span":{"begin":187,"end":194},"obj":"Species"},{"id":"65","span":{"begin":246,"end":256},"obj":"Species"},{"id":"66","span":{"begin":25,"end":70},"obj":"Disease"},{"id":"67","span":{"begin":319,"end":328},"obj":"Disease"}],"attributes":[{"id":"A62","pred":"tao:has_database_id","subj":"62","obj":"Gene:7422"},{"id":"A63","pred":"tao:has_database_id","subj":"63","obj":"Gene:2525"},{"id":"A64","pred":"tao:has_database_id","subj":"64","obj":"Tax:9606"},{"id":"A65","pred":"tao:has_database_id","subj":"65","obj":"Tax:2697049"},{"id":"A67","pred":"tao:has_database_id","subj":"67","obj":"MESH:C538139"},{"subj":"62","pred":"source","obj":"LitCovid-PubTator"},{"subj":"63","pred":"source","obj":"LitCovid-PubTator"},{"subj":"64","pred":"source","obj":"LitCovid-PubTator"},{"subj":"65","pred":"source","obj":"LitCovid-PubTator"},{"subj":"66","pred":"source","obj":"LitCovid-PubTator"},{"subj":"67","pred":"source","obj":"LitCovid-PubTator"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"LitCovid-PD-FMA-UBERON","color":"#b793ec","default":true},{"id":"LitCovid-PD-MONDO","color":"#93ec9d"},{"id":"LitCovid-PD-CLO","color":"#ec93a2"},{"id":"LitCovid-PD-CHEBI","color":"#93bcec"},{"id":"LitCovid-sentences","color":"#d6ec93"},{"id":"LitCovid-PubTator","color":"#e793ec"}]}]}}